Phase
Condition
Vision Loss
Eye Disorders/infections
Eye Disease
Treatment
Test IOL Model DEN00V
Control IOL Model DCB00
Clinical Study ID
Ages > 22 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
INCLUSION CRITERIA
To be considered for enrollment in this study, patient must:
be at least 22 years old
have cataracts in both eyes
sign the written informed consent
be willing and able to comply with examination procedures
understand, read and write English to complete informed consent and questionnaires
be available for study follow-up visits EXCLUSION CRITERIA
Patient will not be eligible to take part in the study if:
currently participating in any other clinical study or have participated in a clinical study during the last 30 days
have a certain disease/illness, such as poorly controlled diabetes
have certain ocular conditions, such as uncontrolled pressure in the eye
taking medication that may affect vision
pregnant, plan to become pregnant during the study, or are breastfeeding
Study Design
Connect with a study center
Empire Eye & Laser Center
Bakersfield, California 93309
United StatesSite Not Available
Harvard Eye Associates
Laguna Hills, California 92653
United StatesSite Not Available
Levenson Eye Associates
Jacksonville, Florida 32204
United StatesSite Not Available
Jones Eye Center
Sioux City, Iowa 51104
United StatesSite Not Available
OCLI Vision
Garden City, New York 11530
United StatesSite Not Available
Cleveland Eye Clinic
Brecksville, Ohio 44141
United StatesSite Not Available
Vance Thompson Vision
Sioux Falls, South Dakota 57108
United StatesSite Not Available
Berkeley Eye Center
Houston, Texas 77027
United StatesSite Not Available
Whitsett Vision Group
Houston, Texas 77055
United StatesSite Not Available
Parkhurst NuVision
San Antonio, Texas 78229
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.